A Novel EPO Receptor Agonist Improves Glucose Tolerance via Glucose Uptake in Skeletal Muscle in a Mouse Model of Diabetes
Figure 3
Dose response of CNTO 530 at day 14. PBS (■) or CNTO 530 was dosed IV at increasing concentrations (0.01□, 0.03♦, 0.1○, 0.3▲) in DIO mice (). (a) Fourteen days after dosing, an IPGTT was performed. (b) The AUC from part A was plotted for each dose of CNTO 530. The results are presented as mean ± SEM. **indicates a P value < .01. ***indicates a P value < .005.
